08:00 , Dec 20, 2010 |  BC Week In Review  |  Financial News

NovImmune financial update

NovImmune raised CHF20 million ($20.3 million) in an extension of a series B round. Existing investor BZ Bank participated in the extension. NovImmune S.A. , Geneva, Switzerland   Business: Autoimmune, Endocrine, Transplant   Date announced:...
01:19 , Dec 18, 2010 |  BC Extra  |  Financial News

NovImmune adds $20.4 million

NovImmune S.A. (Geneva, Switzerland) raised CHF20 million ($20.4 million) in an extension of a series B round from existing investor BZ Bank. NovImmune's lead product, NI-0401 , is in Phase II testing to treat Type...
07:00 , Sep 13, 2010 |  BC Week In Review  |  Financial News

Pevion Biotech Ltd. completes venture financing

Pevion Biotech Ltd. , Ittigen, Switzerland   Business: Infectious, Cancer   Date completed: 9/7/10   Type: Venture financing   Raised: CHF10 million ($9.8 million)   Investors: BZ Bank; BB Biotech Ventures; Core Capital Partners  ...
00:42 , Sep 8, 2010 |  BC Extra  |  Financial News

Pevion raises CHF10 million

Pevion Biotech Ltd. (Ittigen, Switzerland) raised CHF10 million ($9.8 million) in a private round led by existing investor BZ Bank. BB Biotech Ventures and Core Capital Partners, also existing investors, participated. Pevion said it plans...
01:34 , May 12, 2009 |  BC Extra  |  Top Story

NovImmune raises $56.4 million

NovImmune S.A. (Geneva, Switzerland) raised CHF62.5 million ($56.4 million) in an equity financing led by existing investor BZ Bank. Novartis Venture Fund; Ingro Finanz; Varuma; Pictet Private Equity Investors; and Aravis Venture, all also existing...
07:00 , Sep 17, 2007 |  BC Week In Review  |  Company News

Pevion Biotech board of directors update

Pevion Biotech Ltd. , Bern, Switzerland   Business: Infectious   Appointed: Klaus Breiner, venture capital investor at BB Biotech Ventures; and Joseph Manko, investment banker for BZ Bank Aktiengesellschaft  ...
00:41 , Aug 11, 2007 |  BC Extra  |  Financial News

Pevion raises $29.4 million

Pevion (Bern, Switzerland) raised CHF 35 million ($29.4 million) in a series A round led by new investor BZ Bank. BB Biotech Ventures and CC Private Equity Partners, also new investors, and existing investor Bachem...
08:00 , Nov 13, 2006 |  BioCentury  |  Strategy

Expanding the envelope

Until now, immunology play NovImmune S.A. has tried its hand at improving on compounds against medically validated targets and generating difficult-to-make antibodies with improved safety and efficacy. With a fresh CHF58 million ($46 million) from...
01:18 , Oct 31, 2006 |  BC Extra  |  Financial News

NovImmune raises $46.1 million

NovImmune (Geneva, Switzerland) raised CHF58 million ($46.1 million) in a series B round led by new investor BZ Bank. New investor Pictet Private Equity Investors joined existing investors Lombard Odier Darier Hentsch; Novartis Venture Fund;...